Urology and most other medical and surgical specialties saw modest increases in compensation in 2007, but many provider organizations continue to operate at a significant loss, according to findings from the American Medical Group Association?s 2008 Medical Group Compensation and Financial Survey.
Urology and most other medical and surgical specialties saw modest increases in compensation in 2007, but many provider organizations continue to operate at a significant loss, according to findings from the American Medical Group Association’s 2008 Medical Group Compensation and Financial Survey.
Urology posted the second-highest increase in compensation among specialists at 4.5%, surpassed only by cardiac and thoracic surgery, whose compensation jumped 8.11%. Overall, the survey found that 91% of the specialties experienced increases in compensation, with the overall average increase around 3.5%. The primary care specialties saw about a 3.2% increase in 2007, while other medical and surgical specialties averaged around 3.7%.
“The survey indicates that compensation increases continue to fluctuate only marginally for most specialties,” said Donald W. Fisher, PhD, of the American Medical Group Association. “With the negative impact of declining reimbursements, competition for specialists, the cost of new technology, and other factors on practice revenues in most parts of the country, this situation is clearly unsustainable.”
The section of the survey that examines financial operations found that medical groups were operating at an average loss of $4,728 per physician, reflecting a major overall downturn from 2006. Again in 2007, on average, only organizations in the Western United States were operating at a profit ($4,453 per physician), though profits were significantly down.
Median work relative value units matched compensation in most cases. Among surgical specialties, cardiac and thoracic surgery led the pack with 33.2%, followed by urology (13.62%) and OB/GYN (10.66%). In terms of median gross charges, cardiac and thoracic surgery again posted the largest increase (15.97%) among surgical disciplines, followed by emergency medicine (6.17%), general surgery (4.88%), and urology (4.02%).
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.